Skip to content
MARKETS / NYSE / UHS
NYSE · SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC · LARGE CAP

Universal Health Services Inc. UHS

18 fiscal years on record · USD · FY2025 reported · SEC filings only
$17.4B
▲ 9.7% YoY
$1.5B
▲ 30.4% YoY
$849.2M
▼ 24.4% YoY
In brief

What this company does

Universal Health Services, Inc.'s principal business is owning and operating, through its subsidiaries, acute care hospitals and outpatient facilities and behavioral health care facilities. As of February 25, 2026, it owned and/or operated 375 inpatient facilities and 168 outpatient and other facilities located in 40 states, Washington, D.C., the United Kingdom and Puerto Rico. Net revenues from its acute care hospitals, outpatient facilities and commercial health insurer accounted for approximately 57% of its consolidated net revenues during each of 2025 and 2024. Services provided by its hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and/or behavioral health services. As of December 31, 2025, it had approximately 101,500 total employees, consisting of approximately 88,100 employees located in the U.S., of which approximately 65,000 were employed full-time, and approximately 13,400 employees located in the U.K. Universal Health Services, Inc. is a Delaware corporation that was organized in 1979.

Written from the business description in UNIVERSAL HEALTH SERVICES, INC.'s annual report to the U.S. Securities and Exchange Commission, filed 25 February 2026. Every sentence was checked against that document before publication.

Growth
USD 17.4B
Revenue, FY2025 · full 18-year series below
Revenue $B Net income $B
FY2025 · Revenue 17.4 · Net income 1.5
8B16B2008201120142017202020232025
Compound annual growth
+9.0%
+8.5%
+6.7%
+8.8%
+30.1%
+9.5%
+8.1%
+13.3%
+36.2%
+16.0%
+13.1%
+16.5%
+0.0%
+9.7%
+4.5%
+36.5%
+15.3%
+27.1%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +8.5% a year over five years — but profit grew faster: net income at +9.5%, earnings per share at +16.0%.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
9 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 11.5% · Net 8.7%
5%10%2008201120142017202020232025
ROE
FY2025 · ROE 21.4%
10%20%2008201120142017202020232025

Each USD of equity produced 21 cents of profit this year.

Cash & shareholders
USD 1.0B
returned in FY2025 · dividends + net buybacks
Free cash flow $B
FY2025 · FCF 0.8
0.8B1.6B2008201120142017202020232025
Net buybacks $B Dividends $B
FY2025 · Dividends 0.1 · Net buybacks 1.0
0.5B1.0BDividendsNet buybacks2008201120142017202020232025

USD 51.3M in dividends and USD 951.2M in buybacks — 67% of the year's profit went back to shareholders.

Total assetsUSD 15.5B
EquityUSD 7.3B
CashUSD 137.8M
Gross debtUSD 4.8B
Net debtUSD 4.6B
Current ratio1.05×

Net debt stands at 63% of equity.

The 18-year record
18 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 202520242023202220212020201920182017201620152014201320122011201020092008
Revenue $B17.415.814.313.412.611.611.410.810.49.89.08.27.47.06.84.95.25.0
Operating income $B2.01.71.21.01.41.41.21.21.31.31.31.11.00.90.90.50.50.4
EBITDA $B2.62.21.71.51.91.81.71.61.71.61.61.41.41.31.20.70.70.6
Income tax $B0.50.30.20.20.30.30.20.20.40.40.40.30.30.30.20.20.20.1
Net income $B1.51.10.70.71.00.90.80.80.80.70.70.50.50.40.40.20.30.2
Free cash flow $B0.81.10.50.30.01.60.80.60.70.80.70.60.50.40.40.30.20.1
EPS, diluted $23.1016.8210.239.1411.8210.999.138.317.817.146.765.425.144.534.042.342.641.96
Dividend / sh $0.800.800.800.800.80·0.600.40···0.300.200.600.200.200.17·
Payout %3589727556654135868
ROE %21.417.811.911.316.016.015.015.015.816.017.015.617.117.718.612.314.9·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Compare

This company against its peers

Provenance
Company facts, as filed
How we verify · 0 failures in 70 reconciliationsAUDITED

Reconciled in 18 of 19 fiscal years. 6 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityServices-General Medical & Surgical Hospitals, NEC
Listed onNYSE
Incorporated inDelaware
Fiscal year endsDecember 31
Data on record since2008

Share this section

Download image